Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3497-3504

  Voulgaropoulou, Frosso ^a,b   Tan, Benjamin ^a   Soares, Marcelo ^c   Hahn, Beatrice ^c   Ratner, Lee ^a,b,d  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Box 8069   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AMINO ACID ANALYSIS; ARTICLE; BONE MARROW; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THROMBOCYTOPENIA; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0032975094     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3497-3504.1999     Document Type: Article

References (77)

1. Bahner, I., K. Kearns, S. Coutinho, E. H. Leonard, and D. B. Kohn. 1997. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 90:1787-1798.
2. Ballem, P. J., A. Belzberg, D. V. Devine, D. Lyster, B. Spruston, H. Chambers, P. Doubroff, and K. Mikulash. 1992. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327:1779-1784. (Comments, 327:1812-1813, 1992, and 328:1785-1786, 1993.)
3. Boyar, A., and G. Beall. 1991. HIV-seropositive thrombocytopenia: the action of zidovudine. AIDS 5:1351-1356.
4. Carrillo, A., and L. Ratner. 1996. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants. J. Virol. 70:1301-1309.
5. Carrillo, A., D. B. Trowbridge, P. Westervelt, and L. Ratner. 1993. Identification of HIV-1 determinants for T lymphoid cell line infection. Virology 197:817-824.
6. Chelucci, C., M. Federico, R. Guerriero, G. Mattia, I. Casella, E. Pelosi, U. Testa, G. Mariani, H. J. Hassan, and C. Peschle. 1998. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/ precursors and maturing megakaryocytes. Blood 91:1225-1234.
7. Chelucci, C., H. J. Hassan, C. Locardi, D. Bulgarini, E. Pelosi, G. Mariani, U. Testa, M. Federico, M. Valtieri, and C. Peschle. 1995. In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single-cell culture. Blood 85:1181-1187.
8. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
9. Cheng-Mayer, C., C. Weiss, D. Seto, and J. A. Levy. 1989. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA 86:8575-8579.
10. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
11. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1996. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70:9055-9059.
12. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
13. Cocchi, F., A. L. DeVico, A. Garzino-Demo, A. Cara, R. C. Gallo, and P. Lusso. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-1247. (Comment, 3:367-368, 1997.)
14. Cole, J. L., U. M. Marzec, C. J. Gunthel, S. Karpatkin, L. Worford, I. B. Sundell, J. L. Lennox, J. L. Nichol, and L. A. Harker. 1998. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 91:3239-3246.
15. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1777.
16. + progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br. J. Haematol. 85:20-24.
17. Derwart, E. L., J. I. Mullins, P. Gupta, G. H. Learn, Jr., M. Holodniy, D. Katzenstein, B. D. Walker, and M. K. Singh. 1998. Human immunodeficiency virus type 1 populations in blood and semen. J. Virol. 72:617-623.
18. Dennis, L. H., and I. Brodsky. 1965. Thrombocytopenia induced by the Friend leukemia virus. J. Natl. Cancer Inst. 35:993-999.
19. Dennis, L. H., and I. Brodsky. 1965. A dose-response curve employing thrombocytopenia induced by the Friend leukemia virus. Proc. Soc. Exp. Biol. Med. 120:683-685.
20. Dittmar, M. T., G. Simmons, Y. Donaldson, P. Simmonds, P. R. Clapham, T. F. Schulz, and R. A. Weiss. 1997. Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J. Virol. 71:5140-5147.
21. Donaldson, Y. K., J. E. Bell, E. C. Holmes, E. S. Hughes, H. K. Brown, and P. Simmonds. 1994. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J. Virol. 68:5991-6005.
22. Doweiko, J. P. 1993. Hematologic aspects of HIV infection. AIDS 7:753-757. (Editorial.)
23. Dumitrescu, O., M. L. Kalish, S. C. Kliks, C. I. Bandea, and J. A. Levy. 1994. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J. Infect. Dis. 169:281-288.
24. Evans, L. A., T. M. McHugh, D. P. Stites, and J. A. Levy. 1987. Differential ability of human immunodeficiency virus isolates to productively infect human cells. J. Immunol. 138:3415-3418.
25. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
26. Gorny, M. K., J. Y. Xu, V. Gianakakos, S. Kanrowska, C. Williams, H. W. Sheppard, C. V. Hanson, and S. Zolla-Pazner. 1991. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 88:3238-3242.
27. Groenink, M., R. A. Fouchier, S. Broersen, C. H. Baker, M. Koot, A. B. van't Wout, H. G. Huisman, F. Miedema, M. Tersmette, and H. Schuilemaker. 1993. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 260:1513-1516. (Comment, 268:115, 1995.)
28. Harbol, A. W., J. L. Liesveld, P. J. Simpson-Haidaris, and C. N. Abboud. 1994. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev. 8:241-251.
29. Harnly, M. E., S. H. Swan, E. A. Holly, A. Kelter, and N. Padian. 1988. Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS). Am. J. Epidemiol. 128:261-267. (Comment, 130: 1069-1071, 1989.)
30. Higgins, D. G., A. J. Bleasby, and R. Fuchs. 1992. CLUSTAL V: improved software for multiple sequence alignment. Comput. Appl. Biosci. 8:189-191.
31. Higgins, D. G., and P. M. Sharp. 1988. CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73:237-244.
32. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1991. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74.
33. Ichimura, H., S. C. KJiks, S. Visrularatna, C. Y. Ou, M. L. Kalish, and J. A. Levy. 1994. Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res. Hum. Retroviruses 10:263-269.
34. + transformed T-cell lines. Cell. Mol. Biol. 43:1057-1065.
35. Kuiken, C. L., J.-J. de Jong, E. Baan, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66:4622-4627. (Erratum, 66:5704.)
36. Kunzi, M. S., and J. E. Groopman. 1993. Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells. Blood 81: 3336-3342.
37. Lichtman, M. A. 1981. The ultrastructure of the hemopoietic environment of the marrow: a review. Exp. Hematol. 9:391-410.
38. Louache, F., A. Bettaieb, A. Henri, E. Oksenhendler, J. P. Farcet, P. Bierling, M. Seligmann, and W. Vainchenker. 1991. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood 78:1697-1705.
39. Louache, F., A. Henri, A. Bettaieb, E. Oksenhendler, G. Raguin, M. Tulliez, and W. Vainchenker. 1992. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 80: 2991-2999.
40. Lyman, S. D., and S. E. Jacobsen. 1998. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101-1134.
41. Maciejewski, J. P., E. E. Bruening, R. E. Donahue, E. S. Mocarski, N. S. Young, and S. C. St. Jeor. 1992. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
42. Maciejewski, J. P., F. F. Weichold, and N. S. Young. 1994. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-α. J. Immunol. 153:4303-4310.
43. Miles, S. A., R. T. Mitsuyasu, J. Moreno, G. Baldwin, N. K. Alton, L. Souza, and J. A. Glaspy. 1991. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 77:2109-2117.
44. Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J. Virol. 67:5623-5634.
45. Milich, L., B. H. Margolin, and K. Swanstrom. 1997. Patterns of amino acid variability in NSI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 env protein. Virology 239:108-118.
46. Mohle, R., D. Green, M. A. Moore, R. L. Nachraan, and S. Rafii. 1997. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA 94:663-668.
47. Monte, D., H. Groux, B. Raharinivo, B. Plouvier, J. Dewulf, T. Clavel, C. Grangette, G. Torpier, C. Auriault, A. Capron, et al. 1992. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha. Blood 79:2670-2679.
48. Moses, A. V., S. Williams, M. L. Heneveld, J. Strussenberg, M. Rarick, M. Loveless, G. Bagby, and J. A. Nelson. 1996. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87:919-925. (Comment, 88:1897-1898, 1996.)
49. Oksenhendler, E., P. Bierling, F. Ferchal, J. P. Clauvel, and M. Seligmann. 1989. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 110:365-368.
50. Orkln, S. H. 1995. Hematopoiesis: how does it happen? Curr. Opin. Cell Biol. 7:870-877.
51. Poss, M., H. L. Martin, J. K. Kreiss, L. Granville, B. Chohan, P. Nyange, K. Mandaliya, and J. Overbaugh. 1995. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J. Virol. 69:8118-8122.
52. Rafil, S., F. Shapiro, R. Pettengell, B. Ferris, R. L. Nachman, M. A. Moore, and A. S. Asch. 1995. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86:3353-3363.
53. Rusche, J. R., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, P. J. Fischinger, et al. 1988. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA 85:3198-3202. (Errata, 85:8697, 1988, and 86:1667, 1989.)
54. Saitou, N., and M. NeL 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
55. Schuitemaker, H., N. A. Kootstra, R. E. Y. de Goede, F. de Wolf, F. Miedema, and M. Tersmette. 1991. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:356-363.
56. Speck, R. F., K. Wehrly, E. J. Platt, R. E. Atchison, I. F. Charo, D. Kabat, B. Chesebro, and M. A. Goldsmith. 1997. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:7136-7139.
57. + bone marrow cells are infected with HIV in a subset of seropositive individuals. J. Immunol. 149:689-697.
58. Steinberg, H. N., C. S. Crumpacker, and P. A. Chatis. 1991. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J. Virol. 65:1765-1769.
59. Strizki, J. M., A. V. Albright, H. Sheng, M. O'Connor, L. Perrin, and F. González-Scarano. 1996. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J. Virol. 70:7654-7662.
60. Tamalet, C., A. Lafeuillade, N. Yahi,C. Vignoli, C. Tourres,P. Pellegrino, and P. de Micco. 1994. Comparison of viral burden and phenotype of HIV-1 isolates from lymph nodes and blood. AIDS 8:1083-1088.
61. Tavassoli, M., and A. Friedenstein. 1983. Hemopoietic stromal microenvironment. Am. J. Hematol. 15:195-203.
62. Tersmette, M., R. E. Y. de Goede, B. J. M. M. Al, I. N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
63. Tersmette, M., R. A. Gruters, F. de Wolf, R. E. Y. de Goede, J. M. A. Lange, P. T. A. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
64. + cells. Virology 186:313-317.
65. van't Wout, A. B., H. Blaak, L. J. Ran, M. Brouwer, C. Kuiken, and H. Schuitemaker. 1998. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J. Virol. 72:5099-5107.
66. van't Wout, A. B., L. J. Ran, C. L. Kuiken, N. A. Kootstra, S. T. Pals, and H. Schuitemaker. 1998. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J. Virol. 72:488-496.
67. Wachinger, M., T. Saermark, and V. Erfle. 1992. Influence of amphipathic peptides on HIV-1 production in persistently infected T lymphoma cells. FEBS Lett. 309:235-241.
68. Westervelt, P., H. E. Gendelman, and L. Ratner. 1991. Identification of a determinant within the human immunodeficiency virus type 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88:3097-3101.
69. Westervelt, P., D. B. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, and L. Ratner. 1992. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66:2577-2582.
70. Wickenhauser, C., J. Lorenzen, J. Thiele, A. Hillienhof, K. Jungheim, B. Schmitz, M. L. Hansmann, and R. Fischer. 1995. Secretion of cytokines (interleukins-1α, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood 85:685-691.
71. +) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 79:2680-2687.
72. Zauli, G., M. C. Re, L. Gugliotta, G. Visani, N. Vianelli, G. Furlini, and M. La Placa. 1991. Lack of compensatory megakaryocytopoiesis in HIV-1-seropositive thrombocytopenic individuals compared with immune thrombocytopenic purpura patients. AIDS 5:1345-1350.
73. +) hematopoietic progenitor cells. Arch. Virol. 122:271-280.
74. +) cells in AIDS patients. J. Infect. Dis. 166:710-716.
75. + hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1. J. Exp. Med. 183:99-108.
76. Zucker-Franklin, D., and Y. Z. Cao. 1989. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc. Natl. Acad. Sci. USA 86:5595-5599.
77. Zucker-Franklin, D., C. S. Termin, and M. C. Cooper. 1989. Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1). Am. J. Pathol. 134:1295-1303.